Head & Neck/Thyroid Cancers
Conference Coverage
Immunotherapy could fill unmet need in leptomeningeal metastases
More than a third of patients had a CNS response to systemically administered pembrolizumab, including two patients who had long-lived complete...
Clinical Insights
Using telehealth to deliver palliative care to cancer patients
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.
From the Journals
New cancer drugs may have saved more than 1.2 million Americans
Cancer drugs approved between 2000 and 2016 significantly reduced deaths from the most common cancers in the United States.
From the Journals
One-month delay in cancer treatment linked to increase in mortality
The risk of death varied by treatment type.
From the Journals
Real-world results with checkpoint inhibitors found inferior to trial results
Data suggest real-world survival is worse than survival in clinical trials.
Conference Coverage
SRS instead of WBRT for patients with multiple brain metastases
Conference Coverage
Lower BP and better tumor control with drug combo?
Feature
Are oncologists ready to confront a second wave of COVID-19?
Conference Coverage
Clinical factors and treatment tied to COVID-19 mortality in cancer patients
Analyses of CCC19 data revealed factors linked to mortality in patients with COVID-19 and cancer.
Clinical Insights
The scope of under- and overtreatment in older adults with cancer
From the Journals
Cancer disparities: One of the most pressing public health issues
“The burden of cancer is not shouldered equally by all segments of the U.S. population,” the AACR states.